Theseus Pharmaceuticals Inc. (THRX) NASDAQ
$7.15 -0.39 (-5.17%)
Market Cap: $291.82M
As of 05/26/22 03:55 PM EDT. Market closed.
Theseus Pharmaceuticals Inc. (THRX) NASDAQ
$7.15 -0.39 (-5.17%)
Market Cap: $291.82M
As of 05/26/22 03:55 PM EDT. Market closed.
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
2,022
URL
Address
.
PRICE CHART
From:
To:
KEY STATS
Open
$7.31
Previous Close
$7.54
Days Range
$6.73 - $8.04
52 week range
$6.73 - $24.54
Volume
72,003
Avg. Volume (30 days)
62,437
Market Cap
$291.82M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,702,650
Open
$7.31
Previous Close
$7.54
Days Range
$6.73 - $8.04
52 week range
$6.73 - $24.54
Volume
72,003
Avg. Volume (30 days)
62,437
Market Cap
$291.82M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,702,650
Open in:
Open in:
INSIDER TRANSACTIONS FOR THESEUS PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| GORDON CARL L | Director | Jan 21, 2022 | Buy | $9.97 | 111,896 | 1,115,603 | 16,542,652 | Jan 21, 2022, 07:22 PM |
| GORDON CARL L | Director | Jan 20, 2022 | Buy | $9.95 | 35,000 | 348,250 | 16,430,756 | Jan 21, 2022, 07:22 PM |
| GORDON CARL L | Director | Jan 19, 2022 | Buy | $9.97 | 11,521 | 114,864 | 16,395,756 | Jan 21, 2022, 07:22 PM |
| ORBIMED ADVISORS LLC | Director | Jan 21, 2022 | Buy | $9.97 | 111,896 | 1,115,603 | 16,542,652 | Jan 21, 2022, 07:18 PM |
| ORBIMED ADVISORS LLC | Director | Jan 20, 2022 | Buy | $9.95 | 35,000 | 348,250 | 16,430,756 | Jan 21, 2022, 07:18 PM |
| ORBIMED ADVISORS LLC | Director | Jan 19, 2022 | Buy | $9.97 | 11,521 | 114,864 | 16,395,756 | Jan 21, 2022, 07:18 PM |
| GORDON CARL L | Director | Jan 13, 2022 | Buy | $9.43 | 17,320 | 163,328 | 16,384,235 | Jan 13, 2022, 07:27 PM |
| GORDON CARL L | Director | Jan 12, 2022 | Buy | $10.06 | 18,897 | 190,104 | 16,366,915 | Jan 13, 2022, 07:27 PM |
| GORDON CARL L | Director | Jan 11, 2022 | Buy | $10.51 | 8,500 | 89,319 | 16,348,018 | Jan 13, 2022, 07:27 PM |
| ORBIMED ADVISORS LLC | Director | Jan 11, 2022 | Buy | $10.51 | 8,500 | 89,319 | 16,348,018 | Jan 13, 2022, 07:18 PM |
| ORBIMED ADVISORS LLC | Director | Jan 13, 2022 | Buy | $9.43 | 17,320 | 163,328 | 16,384,235 | Jan 13, 2022, 07:18 PM |
| ORBIMED ADVISORS LLC | Director | Jan 12, 2022 | Buy | $10.06 | 18,897 | 190,104 | 16,366,915 | Jan 13, 2022, 07:18 PM |
| CLACKSON TIMOTHY P | President and CEO | Dec 21, 2021 | Buy | $9.76 | 2,600 | 25,381 | 348,530 | Dec 22, 2021, 06:26 PM |
| Dahms Bradford D. | Chief Financial Officer | Dec 21, 2021 | Buy | $10.15 | 1,970 | 20,000 | 1,970 | Dec 22, 2021, 06:21 PM |
| GORDON CARL L | Director | Oct 12, 2021 | Buy | $16.00 | 62,500 | 1,000,000 | 499,150 | Oct 14, 2021, 05:00 PM |
| GORDON CARL L | Director | Oct 12, 2021 | Buy | $16.00 | 562,500 | 9,000,000 | 16,339,518 | Oct 14, 2021, 05:00 PM |
| Shakespeare William | See Remarks | Oct 12, 2021 | Buy | $16.00 | 625 | 10,000 | 388,949 | Oct 14, 2021, 05:00 PM |
| Rock Springs Capital Management LP | 10% Owner | Oct 12, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 599,320 | Oct 14, 2021, 05:00 PM |
| ORBIMED ADVISORS LLC | Director | Oct 12, 2021 | Buy | $16.00 | 62,500 | 1,000,000 | 499,150 | Oct 14, 2021, 05:00 PM |
| ORBIMED ADVISORS LLC | Director | Oct 12, 2021 | Buy | $16.00 | 562,500 | 9,000,000 | 16,339,518 | Oct 14, 2021, 05:00 PM |
| Omega Fund VI, L.P. | Former 10% owner | Oct 12, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 711,479 | Oct 14, 2021, 04:40 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| GORDON CARL L | Director | 01/21/2022 | 1,115,603 |
| GORDON CARL L | Director | 01/20/2022 | 348,250 |
| GORDON CARL L | Director | 01/19/2022 | 114,864 |
| ORBIMED ADVISORS LLC | Director | 01/21/2022 | 1,115,603 |
| ORBIMED ADVISORS LLC | Director | 01/20/2022 | 348,250 |
| ORBIMED ADVISORS LLC | Director | 01/19/2022 | 114,864 |
| GORDON CARL L | Director | 01/13/2022 | 163,328 |
| GORDON CARL L | Director | 01/12/2022 | 190,104 |
| GORDON CARL L | Director | 01/11/2022 | 89,319 |
| ORBIMED ADVISORS LLC | Director | 01/11/2022 | 89,319 |
| ORBIMED ADVISORS LLC | Director | 01/13/2022 | 163,328 |
| ORBIMED ADVISORS LLC | Director | 01/12/2022 | 190,104 |
| CLACKSON TIMOTHY P | President and CEO | 12/21/2021 | 25,381 |
| Dahms Bradford D. | Chief Financial Officer | 12/21/2021 | 20,000 |
| GORDON CARL L | Director | 10/12/2021 | 1,000,000 |
| GORDON CARL L | Director | 10/12/2021 | 9,000,000 |
| Shakespeare William | See Remarks | 10/12/2021 | 10,000 |
| Rock Springs Capital Management LP | 10% Owner | 10/12/2021 | 4,000,000 |
| ORBIMED ADVISORS LLC | Director | 10/12/2021 | 1,000,000 |
| ORBIMED ADVISORS LLC | Director | 10/12/2021 | 9,000,000 |
| Omega Fund VI, L.P. | Former 10% owner | 10/12/2021 | 3,000,000 |
Load More Insider Transactions